Pharmacovigilance and Pharmacoepidemiology as a Guarantee of Patient Safety: The Role of the Clinical Pharmacologist
- PMID: 35743619
- PMCID: PMC9225198
- DOI: 10.3390/jcm11123552
Pharmacovigilance and Pharmacoepidemiology as a Guarantee of Patient Safety: The Role of the Clinical Pharmacologist
Abstract
Recent years, particularly the COVID-19 pandemic, can be considered a turning point for pharmacovigilance and pharmacoepidemiology in terms of their role in drug safety and drug utilisation monitoring in clinical practice [...].
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Pharmacoepidemiology and its input to pharmacovigilance.Therapie. 2016 Apr;71(2):211-6. doi: 10.1016/j.therap.2016.02.016. Epub 2016 Feb 6. Therapie. 2016. PMID: 27080840 English, French.
-
Monitoring medicines use: the role of the clinical pharmacologist.Br J Clin Pharmacol. 2012 Oct;74(4):685-90. doi: 10.1111/j.1365-2125.2012.04316.x. Br J Clin Pharmacol. 2012. PMID: 22554404 Free PMC article. Review.
-
[Investigation in field pharmacoepidemiology: a proposal for the actions of pharmacovigilance in Brazil].Rev Bras Epidemiol. 2011 Dec;14(4):565-79. doi: 10.1590/s1415-790x2011000400004. Rev Bras Epidemiol. 2011. PMID: 22218656 Portuguese.
-
Interest of pharmacoepidemiology in pharmacovigilance: Post-authorization safety studies in regulatory pharmacovigilance activity.Therapie. 2019 Apr;74(2):301-306. doi: 10.1016/j.therap.2019.01.001. Epub 2019 Jan 9. Therapie. 2019. PMID: 30704766
-
An overview of pharmacoepidemiology in New Zealand: medical databases, registries and research achievements.N Z Med J. 2017 Jan 27;130(1449):52-61. N Z Med J. 2017. PMID: 28178730 Review.
Cited by
-
Cancer drugs with high repositioning potential for Alzheimer's disease.Expert Opin Emerg Drugs. 2023 Dec;28(4):311-332. doi: 10.1080/14728214.2023.2296079. Epub 2023 Dec 26. Expert Opin Emerg Drugs. 2023. PMID: 38100555 Free PMC article. Review.
-
Pharmacoepidemiology: An Overview.J Clin Med. 2023 Nov 10;12(22):7033. doi: 10.3390/jcm12227033. J Clin Med. 2023. PMID: 38002647 Free PMC article. Review.
-
Editorial: Pharmacoepidemiology and pharmacovigilance post-marketing drug safety studies.Front Pharmacol. 2024 Aug 20;15:1473052. doi: 10.3389/fphar.2024.1473052. eCollection 2024. Front Pharmacol. 2024. PMID: 39228524 Free PMC article. No abstract available.
-
Exposures and Suspected Intoxications to Pharmacological and Non-Pharmacological Agents in Children Aged 0-14 Years: Real-World Data from an Italian Reference Poison Control Centre.J Clin Med. 2023 Jan 2;12(1):352. doi: 10.3390/jcm12010352. J Clin Med. 2023. PMID: 36615154 Free PMC article.
-
Editorial: Safety of drugs and CAM products in pregnancy and breastfeeding: evidence from clinical toxicology.Front Pharmacol. 2023 Dec 6;14:1340283. doi: 10.3389/fphar.2023.1340283. eCollection 2023. Front Pharmacol. 2023. PMID: 38125890 Free PMC article. No abstract available.
References
-
- Crescioli G., Brilli V., Lanzi C., Burgalassi A., Ieri A., Bonaiuti R., Romano E., Innocenti R., Mannaioni G., Vannacci A., et al. Adverse Drug Reactions in SARS-CoV-2 Hospitalised Patients: A Case-Series with a Focus on Drug-Drug Interactions. Intern. Emerg. Med. 2021;16:697–710. doi: 10.1007/s11739-020-02586-8. - DOI - PMC - PubMed
-
- Lombardi N., Crescioli G., Bettiol A., Tuccori M., Capuano A., Bonaiuti R., Mugelli A., Venegoni M., Vighi G.D., Vannacci A., et al. Italian Emergency Department Visits and Hospitalizations for Outpatients’ Adverse Drug Events: 12-Year Active Pharmacovigilance Surveillance (The MEREAFaPS Study) Front. Pharmacol. 2020;11:412. doi: 10.3389/fphar.2020.00412. - DOI - PMC - PubMed
-
- Perrone V., Conti V., Venegoni M., Scotto S., Esposti L.D., Sangiorgi D., Prestini L., Radice S., Clementi E., Vighi G. Seriousness, Preventability, and Burden Impact of Reported Adverse Drug Reactions in Lombardy Emergency Departments: A Retrospective 2-Year Characterization. Clin. Outcomes Res. 2014;6:505–514. doi: 10.2147/CEOR.S71301. - DOI - PMC - PubMed
-
- Lombardi N., Crescioli G., Bettiol A., Menniti-Ippolito F., Maggini V., Gallo E., Mugelli A., Vannacci A., Firenzuoli F. Safety of Complementary and Alternative Medicine in Children: A 16-Years Retrospective Analysis of the Italian Phytovigilance System Database. Phytomedicine. 2019;61:152856. doi: 10.1016/j.phymed.2019.152856. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources